KAREX Share Price Performance
RM 0.99
0.15 (17.06%)
Price RM 0.99
Share PriceRM 0.99
Why Investors Shouldn't Be Surprised By Karex Berhad's (KLSE:KAREX) P/S
Oct 09
Karex Berhad Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
KAREX Community Narratives
There are no narratives available yet.
Recent KAREX News & Updates
Karex Berhad Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0.0002
- Gross Margin
- 31.00%
- Net Profit Margin
- 0.042%
- Debt/Equity Ratio
- 33.0%
Karex Berhad Competitors
Snowflake Analysis
About KAREX
- Founded
- 1988
- Employees
- 3149
- CEO
- WebsiteView website
Karex Berhad, an investment holding company, manufactures and sells condoms in Malaysia. The company offers personal lubricants; probe covers; and catheters for transurethral drainage of the urinary bladder, as well as gloves. It also offers hand sanitizer and pre-vulcanised latex products. In addition, the company engages in wholesale healthcare product related business. Karex Berhad operates in the Americas, Asia, Europe, and Africa. Karex Berhad serves brand owners, governments, non-governmental organizations, and retail purchasers. The company was founded in 1988 and is based in Port Klang, Malaysia.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Malaysian Market Performance
- 7 Days: -0.4%
- 3 Months: 5.8%
- 1 Year: -0.8%
- Year to Date: -2.3%
In the last week, the market has been flat. Similarly, the market is flat for the past 12 months. Looking forward, earnings are forecast to grow by 9.9% annually. Market details ›